|
|
|
Volumn 26, Issue 5 SUPPL. 17, 1999, Pages 14-18
|
|
Docetaxel (Taxotere) as monotherapy in the treatment of hormone- refractory prostate cancer: Preliminary results
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANDROGEN;
DOCETAXEL;
GONADORELIN DERIVATIVE;
PROSTATE SPECIFIC ANTIGEN;
ADULT;
AGED;
ALOPECIA;
ANOREXIA;
CANCER HORMONE THERAPY;
CANCER RESISTANCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
EDEMA;
FATIGUE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
MYALGIA;
NEUTROPENIA;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
SMALL INTESTINE OBSTRUCTION;
STOMATITIS;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS, HORMONE-DEPENDENT;
PACLITAXEL;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TAXOIDS;
|
|
EID: 0033434094
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (257)
|
|
References (10)
|
